Specifically, the first application is devoted to study the association between a single nucleotide polymorphism (SNP) and CRC in carriers of a pathogenic variant in the PMS2 gene while the second one focuses on the association of a 161 SNP‐based PRS with breast cancer. Here, PMS2 is linked to breast cancer.